# Does fluralaner (Exzolt® 5%) affect the enzootic stability of tick fever in beef calves subjected to strategic tick control in a tropical region?

**Authors:** Lidia Mendes de Aquino, Igor Maciel Lopes de Morais, Vanessa Ferreira Salvador, Luccas Lourenzzo Lima Lins Leal, Nathalia Braz Ribeiro, Luciana Maffini Heller, Gabriel Lopes Tamiozo, Raphaela Bueno Mendes Bittencourt, Nicolas Jalowitzki de Lima, Lorena Lopes Ferreira, Daniel de Castro Rodrigues, Tom Strydom, Siddartha Torres, Vando Edésio Soares, Caio Marcio de Oliveira Monteiro, Felipe da Silva Krawczak, Welber Daniel Zanetti Lopes

PMC · DOI: 10.1186/s13071-025-07012-6 · Parasites & Vectors · 2025-10-17

## TL;DR

This study examines if using fluralaner to control ticks in beef calves affects the spread of tick fever pathogens in tropical regions.

## Contribution

The study evaluates the impact of fluralaner on enzootic stability of tick fever pathogens in beef calves in a tropical setting.

## Key findings

- Fluralaner-treated calves had significantly lower tick counts compared to the control group at 60 and 241 days.
- Enzootic stability for Babesia bovis was achieved earlier in fluralaner-treated calves compared to the control group.
- Fluralaner did not compromise the development of enzootic stability for tick fever pathogens in beef calves.

## Abstract

Little is known about the impact of fluralaner on herd enzootic stability regarding tick fever pathogens (TFPs). This study aimed to assess whether implementing strategic control of Rhipicephalus microplus using fluralaner could influence the enzootic stability of beef herds regarding TFPs on a farm where this compound had never been previously used.

One hundred Bos taurus indicus calves were divided into two groups of 50 animals each. One group underwent strategic tick control with pour-on fluralaner at 2.5 mg/kg (FLU), while the control group received a pour-on combination of fipronil 1.25 mg/kg + fluazuron 2.5 mg/kg (FIFLUA), a protocol used on the farm for 12 years. Calves were monitored from 25 to 241 days of age (weaning). During this period, in addition to acaricide treatments, tick counts and TFP diagnosis via indirect enzyme-linked immunosorbent assay (iELISA), quantitative polymerase chain reaction (qPCR), and blood smears were conducted in both groups.

FIFLUA animals received four acaricide treatments at 25, 60, 135, and 188 days of age, with intervals of 35, 75, and 53 days. FLU animals received three acaricide treatments, at 25, 135, and 188 days of age, with intervals of 110 and 53 days. The average tick count in the FLU group was significantly lower than in the FIFLUA group at 60 days (Kruskal–Wallis, H = 97.85, df = 1, P < 0.0001) and 241 days (H = 18.12, df = 1, P < 0.0001). Anaplasma marginale bacteremia was lower in the FLU group at 60 days (H = 3.98, df = 1, P = 0.0459). Serologically, enzootic stability for Babesia bovis was achieved at 135 and 188 days in the FLU and FIFLUA groups, respectively. For B. bigemina, over 75% of calves in both groups showed antibodies at 60 and 188 days, respectively. For A. marginale, enzootic stability was reached at 188 days (FLU) and 241 days (FIFLUA).

Strategic tick control with fluralaner did not compromise the development of enzootic stability to B. bovis, B. bigemina, and A. marginale. Over 75% of FLU-treated calves showed seroconversion at 133, 60, and 188 days, respectively.

## Linked entities

- **Chemicals:** fluralaner (PubChem CID 25144319), fipronil (PubChem CID 3352), fluazuron (PubChem CID 65651)

## Full-text entities

- **Diseases:** bacteremia (MESH:D016470), Anaplasma marginale (MESH:D000712), tick fever (MESH:D005334), TFP (MESH:C566945)
- **Chemicals:** fluralaner (MESH:C000591860), fluazuron (MESH:C104929), fipronil (MESH:C082360)
- **Species:** Bos indicus (Indicine cattle, species) [taxon 9915], Anaplasma marginale (species) [taxon 770], Babesia bovis (species) [taxon 5865], Bos taurus (bovine, species) [taxon 9913], Rhipicephalus microplus (cattle tick, species) [taxon 6941], Babesia bigemina (species) [taxon 5866]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12535032/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12535032/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12535032/full.md

---
Source: https://tomesphere.com/paper/PMC12535032